Asia

The latest pharma news from Asia — covering drug approvals, manufacturing, market expansion, and biopharma deals across the region's top markets.

Asia
Pharma

Novartis, Shionogi, ArriVent—Fierce Pharma Asia

Novartis bought an mRNA-coded autoimmune T-cell engager. Shionogi will pay $2 billion to acquire IntraBio. ArriVent's EGFR inhibitor failed in phase 3.
Angus Liu Oct 9, 2026 8:30am
Asia

AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia

Oct 2, 2026 9:35am
The entrance of Asahi Kasei Corporations headquarters

Asahi Kasei wraps years of global dealmaking into a single brand

Oct 1, 2026 7:16am
Stop sign and red lights at traffic intersection

Tagrisso rival loses EU approval after AZ legal challenge

Sep 30, 2026 11:13am
Asia

Lilly-InnoCare, Elevar, China's 5-year plan—Fierce Pharma Asia

Sep 25, 2026 9:38am
pay deal hand over cash licensing transaction money

Boehringer Ingelheim divests biologics CDMO unit in China

Sep 24, 2026 11:38am